Neoadjuvant ICI Without Chemotherapy Demonstrates Potential Efficacy in Patients with Early-Stage TNBC By Ogkologos - November 21, 2024 835 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the BELLINI study Source RELATED ARTICLESMORE FROM AUTHOR Safety and Antitumour Activity of Setidegrasib in Patients with Previously Treated Advanced KRAS p.G12D-mutated NSCLC and PADC EMA Recommends Granting a Marketing Authorisation for Poherdy Whole-Genome Sequencing Meets Diagnostic Requirements in Routine Practice for Patients with Solid Cancers MOST POPULAR Cancer Research UK’s charity Christmas cards now available October 28, 2021 Nivolumab-Based Combinations Improve Survival in Advanced Esophageal Cancer June 17, 2021 Leveraging Extensive Real-World Data to Systematically Identify Mutations that Predict the... July 11, 2022 A Combination of Amivantamab and Lazertinib Shows Durable Clinical Activity in... October 10, 2023 Load more HOT NEWS 2-Year-Old Cancer Survivor With Down Syndrome Hears For First Time: ‘Her... 9-Year-Old Has His Final Cancer Treatment After 3 Years – Breaks... Oncology Research Rebounds from Pandemic Low, but Shows Cancer Patients Need... Enzalutamide Plus ADT Significantly Prolongs Survival in Patients with Metastatic Hormone-Sensitive...
